首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Therapeutic advances in cardiovascular disease

缩写:

ISSN:1753-9447

e-ISSN:1753-9455

IF/分区:3.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引430
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Muhammad Saad,Andrisael Garcia Lacoste,Pooja Balar et al. Muhammad Saad et al.
Introduction: Thyroid hormone (TH) has an essential role on the functional capability of cardiac muscle with its gene modulation and induction of vasodilatory effects. There is considerable evidence to suggest the role of...
Virna Margarita Martín Giménez,León Ferder,Felipe Inserra et al. Virna Margarita Martín Giménez et al.
COVID-19 is said to be a pandemic that does not distinguish between skin color or ethnic origin. However, data in many parts of the world, especially in the United States, begin to show that there is a sector of society suffering a more sig...
Neil Ruparelia,Vasileios Panoulas Neil Ruparelia
Aims: To determine whether the number of patients presenting with acute coronary syndromes has reduced during the COVID-19 pandemic. Methods: ...
Shigenori Ito,Kanako Kinoshita,Akiko Endo et al. Shigenori Ito et al.
Aim: To evaluate inter-core laboratory variability of quantitative coronary angiography (QCA) parameters in comparison with intra-core laboratory variability in a randomized controlled trial evaluating drug-eluting stents...
Athar Ansari,Moiz Ali Shah,Manaim Amir Shah et al. Athar Ansari et al.
Background: We aimed to investigate the safety of endovascular procedures undertaken in a single outpatient center located in a rural, underserved area. Endovascular procedures for Peripheral Arterial Disease (PAD) have b...
Motoaki Sano Motoaki Sano
This review focuses on the pathogenic role of sodium glucose cotransporter (SGLT)-2 in the development of renal dysfunction and heart failure in patients with diabetes, by emphasizing the concept of reno-cardiac syndrome (kidney injury wors...
Mikayla Muzzey,Katie B Tellor,Karthik Ramaswamy et al. Mikayla Muzzey et al.
Introduction: Current atrial fibrillation (AF) guidelines recommend flecainide as a first-line rhythm control option in patients without structural heart disease. While there is proven efficacy in clinical trials and guid...
Lucia Dallapellegrina,Edoardo Sciatti,Enrico Vizzardi Lucia Dallapellegrina
Ivabradine is a pure heart-rate lowering drug that is nowadays used, accordingly to the last ESC Guidelines, to reduce mortality and heart failure (HF) hospitalization in patients with HF with reduced ejection fraction and in symptomatic pa...